Search

everythinglearnresearchcommunity

for

Search:↓

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Two rare bald spots on the back of the scalp were found to be lupus, not alopecia areata.

Estrogen therapy helped regrow hair in a bald man.

Redefining drug dosages is crucial when repurposing them for new uses.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Systemic lupus erythematosus caused severe abdominal issues in a Sudanese woman.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

Oral calcitriol helped improve scleroderma and hair regrowth in a young woman.

A young woman with severe symptoms was diagnosed with SLE and improved significantly after treatment.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Watching, not removing, skin growths with moderate atypia and positive edges is okay; patients may get melanoma elsewhere, especially if they've had it before.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.